Lipolasic (Carbomer)

Carbomer forms a three‑dimensional hydrogel when mixed with water. This hydrogel creates a high‑viscosity matrix that adheres to the conjunctiva and cornea, prolonging the residence time of the eye drop on the eye surface and improving tear‑film stability and drug retention.

The appropriate dose of Lipolasic is determined by the prescribing eye‑care professional based on the specific condition, severity, and patient response. The prescriber will provide instructions on the number of drops, frequency, and duration of treatment.

Carbomer is generally considered to have low systemic absorption when applied topically to the eye. However, safety data in pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit profile before prescribing Lipolasic to pregnant or nursing individuals.

To order Lipolasic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with standard aqueous eye drops, Lipolasic’s carbomer‑based gel offers higher viscosity, which can prolong ocular surface contact and reduce the frequency of dosing. Unlike preservative‑containing drops, it may cause less irritation in sensitive eyes, but individual tolerance varies.

Store Lipolasic at room temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain sterility and gel consistency.

Lipolasic is applied topically to the eye as directed by the prescriber. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place the recommended number of drops onto the conjunctival sac. Avoid touching the tip of the container to the eye or any surface.

Serious risks, although rare, include allergic reactions such as swelling, itching, or rash, and severe ocular inflammation that may lead to corneal damage or vision loss. Any signs of persistent pain, worsening redness, or visual changes should prompt immediate medical evaluation.

Lipolasic should be avoided in individuals with a known hypersensitivity to carbomer or any excipients in the formulation. Patients with active ocular infections, uncontrolled inflammation, or those using incompatible ophthalmic products without professional guidance should also refrain from using it.